Imperative Care has announced the commercial launch of the Zoom 4S catheter—an advanced aspiration thrombectomy device—and the first acute ischaemic stroke patient cases with this new product.
“In my early experience with Zoom 4S, I have found that it integrates seamlessly within the Zoom stroke system, helping reduce guesswork when selecting the optimal device setup for each patient’s anatomy,” said Chip Wiginton (Prisma Health Greenville Memorial Hospital, Greenville, USA). “Zoom 4S also provides a purposefully designed option for employing ADAPT [a direct aspiration first-pass technique] 2.0, offering me procedural control through a stable platform for intracranial access, reliable clot ingestion using asymmetric aspiration, and continuous dual aspiration [CDAT] applied to both Zoom 7X and Zoom 4S catheters. We look forward to further understanding the potential impact of this system in helping make stroke procedures faster and simpler.”
According to Imperative, the Zoom 4S catheter was built for ease of use, empowering physicians with a device that is designed to navigate a broad range of patient anatomies. The Zoom 4S catheter is intended to bring the benefits of the ADAPT 2.0 technique to more patients—with Imperative’s wider goal being the systematisation of stroke treatment.
The company also states that the ADAPT 2.0 technique was created to enable: an intracranial 0.088-inch catheter to be advanced closer to the clot; aspiration through an asymmetric tip catheter with the goal of more complete clot ingestion; and the enhanced power of aspiration through CDAT applied to two catheters. The original ADAPT technique—initially studied and published in 2014—had a transformational impact on stroke thrombectomy by demonstrating the clinical value of direct aspiration as a frontline treatment method for achieving excellent clinical and angiographic outcomes with efficiency, and ease of use, Imperative further claims.
“At Imperative Care, we believe that it is our responsibility to bring the most advanced technologies to market, with the goal of improving patient outcomes by shaping the arc of innovation in stroke care,” said Richard Leparmentier, Imperative’s chief technology officer. “With a focus on reducing treatment times and streamlining stroke procedures, we have purposefully engineered one simple Zoom setup to bring the key procedural benefits of the ADAPT 2.0 technique to more patients. With the introduction of Zoom 4S, Imperative Care is heralding this new chapter of stroke care, as we believe this combination of technologies will provide physicians with the confidence to effectively address a broad range of clot locations using a single setup.”
